iShares U.S. Pharmaceuticals ETF

People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…

Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…

Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…

People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…

Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…

A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player…

The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…

Photo illustration of a group of weight loss medications on a white background. Ucg | Universal Images Group…

Johnson & Johnson shares fell Tuesday despite a mostly strong second-quarter earnings report and an increase to its…

Johnson & Johnson shares have showed signs of life ahead of earnings. For the stock to keep running,…

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press |…

Novo’s Wegovy pill improves weight loss after switch from injections